NCC-LMS2-C1

$600$1,500

Description

Cell line name NCC-LMS2-C1
Accession CVCL_A4EE
Resource Identification Initiative To cite this cell line use: NCC-LMS2-C1 (RRID:CVCL_A4EE)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 46 hours (PubMed=33001379).
Derived from site: Metastatic; Thigh; UBERON=UBERON_0000376.
Disease Leiomyosarcoma (NCIt: C3158)
Leiomyosarcoma (ORDO: Orphanet_64720)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 90Y
Category Cancer cell line
STR profile

Source(s): PubMed=33001379

Markers:

Amelogenin X
CSF1PO 11
D5S818 13
D7S820 12
D13S317 11,13
D16S539 9
D21S11 29
TH01 9
TPOX 8,11
vWA 17

Publications
PubMed=33001379; DOI=10.1007/s13577-020-00443-6
Noguchi R., Yoshimatsu Y., Ono T., Sei A., Hirabayashi K., Ozawa I., Kikuta K., Kondo T.
Establishment and characterization of NCC-LMS2-C1-a novel patient-derived cancer cell line of leiomyosarcoma.
Hum. Cell 34:279-288(2021)

Cross-references
Encyclopedic resources Wikidata; Q105510289

Additional information

ユーザー種別

Academia/non-profit organization, For-profit organization

Reviews

There are no reviews yet.

Be the first to review “NCC-LMS2-C1”

Your email address will not be published. Required fields are marked *

CAPTCHA